Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background And Aim: While blood pressure (BP) and high-sensitivity C-reactive protein (HS-CRP) are established stroke risk factors, their synergistic effects in normotensive populations remain unclear. This study investigates HS-CRP's modifying role in BP-stroke risk associations among Chinese adults without hypertension.

Methods And Results: This study included 4509 participants aged ≥45 years from the China Health and Retirement Longitudinal Study (CHARLS). Blood samples and blood pressure measurements within the normal range (SBP/DBP <140/90 mm Hg) were collected at baseline and stroke events were collected during 9 years of follow-up. Multivariate Cox proportional hazards regression models assessed the association between elevated BP and stroke risk stratified by HS-CRP levels. During the 9-year follow-up, 316 participants had a stroke event. In the high HS-CRP levels, higher SBP [hazard ratio (HR):1.40, 95 % confidence interval (CI): 1,19-1,64], higher DBP (HR:1.32, 95 % CI:1.13-1.56), and higher MAP (HR:1.39, 95 % CI:1.18-1.64) were associated with the risk of stroke (all P<0.001). Linear dose-response associations were found between SBP, DBP, MAP, and stroke risk (P<0.001). However, in the low HS-CRP levels, higher BP was not associated with stroke risk. Linear dose-response associations weren't found between BP and stroke risk. There was an interaction between HS-CRP and SBP on the risk of future stroke events (P = 0.006).

Conclusions: Elevated BP within normal ranges (SBP, DBP, MAP) was associated with an increased risk of stroke in only high HS-CRP levels. HS-CRP may be an important factor affecting the association between elevated normal BP and stroke risk.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.numecd.2025.104230DOI Listing

Publication Analysis

Top Keywords

blood pressure
12
stroke risk
8
modifying effects
4
effects hs-crp
4
hs-crp association
4
blood
4
association blood
4
pressure stroke
4
risk non-hypertensive
4
non-hypertensive population
4

Similar Publications

Background: Experience with icodextrin use in children on long-term peritoneal dialysis is limited. We describe international icodextrin prescription practices and their impact on clinical outcomes: ultrafiltration, blood pressure control, residual kidney function (RKF), technique and patient survival.

Methods: We included patients under 21 years enrolled in the International Pediatric Peritoneal Dialysis Network (IPPN) between 2007 and 2024, on automated PD with a daytime dwell.

View Article and Find Full Text PDF

Introduction: Hypertension, the most common adverse events associated with bevacizumab (BEV) treatment, has been proposed as a potential biomarker of treatment response in glioblastoma (GBM) patients. This study aimed to evaluate whether the timing of hypertension serves as a prognostic value in GBM patients.

Methods: This retrospective study consisting of 56 GBM patients treated with initial BEV between 2013 and 2024.

View Article and Find Full Text PDF

Portopulmonary hypertension (POPH), a subtype of pulmonary arterial hypertension (PAH), develops with portal hypertension and may persist after liver transplantation. While there have been successes using balloon-occluded retrograde transvenous obliteration (BRTO) for POPH, no reports exist on long-term follow-up. A 60-year-old man with hepatitis C cirrhosis developed POPH.

View Article and Find Full Text PDF

Anal fissure causes pain and bleeding during or after bowel movements, significantly impacting individuals' quality of life. Current treatments aim to interrupt this cycle but have associated risks and limitations. The emergence of arginine, crucial for protein creation and nitric oxide (NO) production, presents an intriguing therapeutic avenue by the impact on reducing anal sphincter pressure and enhancing anoderm blood flow, due to its roles in vasodilation, anti-inflammatory responses, and collagen synthesis, which can promote wound healing and highlighting its potential as an alternative therapy.

View Article and Find Full Text PDF

Intracranial venous pressures and endovascular outcomes in pediatric patients with cerebral venous sinus stenosis.

Childs Nerv Syst

September 2025

Department of Neurosurgery, Division of Pediatric Neurosurgery, University of Alabama at Birmingham, Children's of Alabama, 1600 7TH Avenue South, Lowder 400, Birmingham, AL, 35233, USA.

Purpose: Diagnostic cerebral venograms are the gold standard for evaluating cerebral venous sinus stenosis (CVSS). Venous sinus stenting (VSS) and less commonly venous sinus angioplasty are emerging endovascular treatments in pediatric patients. This study examines the baseline intracranial venous pressures and postoperative endovascular outcomes in pediatric patients with CVSS.

View Article and Find Full Text PDF